Related Experiment Videos
Improved test for IgM antibody to Epstein-Barr virus using an absorption step with Staphylococcus aureus
The Journal of Infectious Diseases
|October 1, 1982
Summary
A new method using Staphylococcus aureus and protein A significantly improves IgM antibody detection for Epstein-Barr virus (EBV) infections. This enhances diagnostic accuracy by reducing background noise and eliminating false positives.
Area of Science:
- Immunology
- Virology
- Medical Diagnostics
Background:
- Accurate detection of IgM antibody to Epstein-Barr virus (EBV) is crucial for diagnosing acute infections.
- Traditional methods can suffer from nonspecific background fluorescence and false-positive results.
- Rheumatoid factor in patient serum can interfere with IgM antibody assays.
Purpose of the Study:
- To improve the method for determining IgM antibody levels to EBV capsid antigen.
- To reduce nonspecific background fluorescence in antibody testing.
- To eliminate false-positive reactions caused by rheumatoid factor.
Main Methods:
- Utilizing Staphylococcus aureus cells containing protein A for serum absorption.
- Applying this absorption step to unfractionated test serum before analysis.
- Testing serum for IgM antibody to EBV capsid antigen using immunofluorescence.
Main Results:
- Nonspecific background fluorescence was significantly decreased.
- Detection of specific fluorescent reactions in low-level antibody samples was facilitated.
- False-positive reactions due to rheumatoid factor were eliminated.
- Incubation time for test serum with EBV-infected cells was shortened.
Conclusions:
- The improved antibody test enhances the laboratory diagnosis of acute EBV infections.
- This method aids in identifying EBV infections, even those without a heterophil antibody response.
- The absorption technique offers a more reliable and efficient diagnostic tool for EBV.